LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today announced that Damien McDonald, Chief Executive Officer of LivaNova, and Vivid Sehgal, Chief Financial Officer of LivaNova, will be presenting at the Barclays Global Healthcare Conference in Miami, Fla., on Thursday, March 16, 2017 at 11:15 a.m. Eastern Daylight Time.
The discussion will be available to all interested parties through a live audiocast accessible via the investor relations section of LivaNova’s website at http://Investor.LivaNova.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. A replay of the webcast will be available on the LivaNova website approximately 24 hours after the live presentation for 90 days after the event.
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. LivaNova’s advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. Headquartered in London and with a presence in more than 100 countries worldwide, the company employs more than 4,500 employees. LivaNova operates as three business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm Management, with operating headquarters in Mirandola (Italy), Houston (U.S.A.) and Clamart (France), respectively.
For more information, please visit www.LivaNova.com.